Becker’s asked 14 healthcare leaders what steps they’re taking to align quality, Safety, and financial performance in 2026.
Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results